Cyclo Therapeutics Inc CYTH

23h ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Ascendiant Capital Initiates Coverage of Cyclo Therapeutics (CYTH) with Buy Recommendation

1d ago, source:

Fintel reports that on April 22, 2024, Ascendiant Capital initiated coverage of Cyclo Therapeutics ( NasdaqCM:CYTH) with a Buy recommendation.

Cyclo Therapeutics Inc - Ordinary Shares - Class A

1mon ago, source: U.S. News & World Report

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick ...

Pleasing Signs As A Number Of Insiders Buy Cyclo Therapeutics Stock

14d ago, source:

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying ...

Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

1mon ago, source: Stockhouse

continued efforts to bolster cash position and extend runway through clinical and regulatory milestones Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the ...

Buy Rating Affirmed for Cyclo Therapeutics on Strong Clinical and Financial Prospects

1mon ago, source: Business Insider

Maxim Group analyst Jason McCarthy maintained a Buy rating on Cyclo Therapeutics (CYTH – Research Report) yesterday and set a price target of $4.00. Jason McCarthy has given his Buy rating due ...

Analysts Offer Insights on Healthcare Companies: Cyclo Therapeutics (CYTH), CytomX Therapeutics (CTMX) and Pacific Biosciences (PACB)

2d ago, source:

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cyclo Therapeutics (CYTH – Research Report), ...

Cyclo Therapeutics Reports Third Quarter 2023 Financial Results

5mon ago, source: Finanznachrichten

Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with disease.

Cyclo Therapeutics, Inc. (CYTHW)

1mon ago, source: Yahoo Finance

GAINESVILLE, Fla., March 18, 2024--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing ...

Cyclo Therapeutics Inc. Wt

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Cyclo Therapeutics Inc CYTH

5mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...